News
The up move in the stock came after the company arm Eugia Pharma Specialities, received final approval from USFDA to ...
16h
Vietnam Investment Review on MSNAscletis Reports Positive U S Phase Ib Results for ASC30 Submits Phase IIa Protocol to FDAAscletis Pharma Inc. (HKEX:1672, "Ascletis") announces today positive topline results of its randomized, double-blind, placebo-controlled Phase Ib multiple ascending dose (MAD) study (NCT06680440), ...
Eugia Pharma, a subsidiary of Aurobindo Pharma, has secured final USFDA approval for manufacturing and marketing Dasatinib ...
U.S. stock futures saw a rise after President Trump clarified that he did not intend to remove Federal Reserve Chairman ...
Indian equities extended gains for the seventh straight session on Wednesday, with the BSE Sensex jumping 520.90 points (0.65 ...
UTs did not submit NSQ data with Centre in March: Gireesh Babu, New Delhi Wednesday, April 23, 2025, 08:00 Hrs [IST] The number of states failing to submit the mon ...
The shares of the Mid-Cap company specializing in the development, manufacturing, and commercialization of generic ...
Every bit of magnesium counts for a healthy body and mind, dietitians say. Fruits with magnesium can be an accessible way to ...
By staying true to its core values of inclusivity, health, sustainability, and excellence, the TCS World 10K Bengaluru ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results